Cyber warning letters
This article was originally published in The Tan Sheet
Executive Summary
FDA has issued several "cyber" letters to Internet dietary supplement marketers for promoting products with improper claims. Cosmeceutical Technologies received a letter from the agency stating that its HoodiThin weight-loss supplement carried inappropriate drug claims on the firm's promotional website. Physician Formulas also made drug claims for its Serrapeptase anti-inflammatory, 5-HTP anti-depressant and Prostate Power Rx supplements, according to a separate FDA letter. Additionally, FDA sent a follow-up letter to Torica Productions concerning statements made for its product The Greatest Vitamin in the World that the agency cited in a letter sent last July. The agency particularly objected to claims and testimonials touting the product's benefits for conditions such as diabetes, stroke, heart disease, insomnia, cancer and arthritis, which would require the product to be regulated as a drug...